COVID-19 Research Contributions from Partners in Greater Philadelphia’s Cell & Gene Therapy and Connected Health Initiative Impact Global Health

Partners in Greater Philadelphia’s Cell & Gene Therapy and Connected Health Initiative continue to make significant contributions to the response to SARS-CoV-2, impacting human health not just regionally, but globally as well.  The Chamber of Commerce for Greater Philadelphia’s regional CEO Council for Growth has compiled a list of just some of the recent research and development contributions made by its partners in the Initiative. The round-up includes research updates from Penn Medicine on vaccine development; Children’s Hospital of Philadelphia on COVID-19 tracking; ChristianaCare on gene editing; and Aramark on the creation of a workplace safety digital product.

Penn Medicine

Penn Medicine […]

Discovery Starts in Greater Philadelphia

The Greater Philadelphia region is the original home of cell and gene therapy. This is where the field started two decades ago, was nurtured, and where it continues to rapidly grow.

Cell & Gene Therapy and Connected Health Initiative

This initiative recognizes Greater Philadelphia’s leadership in several of the fastest-growing subsectors of the health care industry and is designed to leverage our specialized assets to accelerate growth.  It prioritizes Greater Philadelphia being recognized as the global hub of research, talent, capital, and companies in cell & gene therapy, gene editing, and connected health. Learn More

Go to Top